Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201320142015201620172018
Sales26 50523 00623 92327 38029 27830 419
Operating income (EBITDA)8 8838 0457 0289 30110 12410 680
Operating profit (EBIT)8 0156 5945 7297 2078 0768 624
Pre-Tax Profit (EBT)6 6472 96810 5263 5616 5877 555
Net income5 6282 7568 4222 6014 2544 951
P/E ratio14,624,37,9730,518,015,8
EPS (GBp )11156,717248,181,593,1
Dividend per Share (GBp )78,080,080,081,180,280,6
Yield4,84%5,81%5,83%5,53%5,47%5,49%
Reference price (GBp )1611.513761373146714671467
Announcement Date02/05/2014
12:00pm
02/04/2015
03:18pm
02/03/2016
12:00pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201320142015201620172018
Debt12 64514 37710 72713 63613 01011 934
Finance------
Operating income (EBITDA)8 8838 0457 0289 30110 12410 680
Leverage
(Debt/EBITDA)
1,42x1,79x1,53x1,47x1,29x1,12x
Capital Expenditure1 1881 1881 3801 5961 5541 542
Book Value Per Share (BVPS)146 PNC87,6 PNC106 PNC66,4 PNC54,5 PNC88,8 PNC
Cash Flow per Share149 PNC108 PNC53,2 PNC112 PNC141 PNC150 PNC
Announcement Date02/05/2014
12:00pm
02/04/2015
03:18pm
02/03/2016
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 71 534 M GBP -
Entreprise Value (EV) 85 170 M GBP 84 544 M GBP
Valuation 2016e 2017e
P/E ratio (Price / EPS) 30,5x 18,0x
Capitalization / Revenue 2,61x 2,44x
EV / Revenue 3,11x 2,89x
EV / EBITDA 9,16x 8,35x
Yield (DPS / Price) 5,53% 5,47%
Price to book (Price / BVPS) 22,1x 26,9x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 26,3% 27,6%
operating Leverage (Delta EBIT / Delta Sales) 1,79x 1,74x
Net Margin (Net Profit / Revenue) 9,50% 14,5%
ROA (Net Profit / Asset) 7,93% 10,1%
ROE (Net Profit / Equities) 108% 224%
Rate of Dividend 169% 98,5%
Balance Sheet Analysis 2016e 2017e
CAPEX / CA   5,83% 5,31%
Cash Flow / Sales 20,0% 23,6%
Capital Intensity (Assets / Sales) 1,20x 1,45x
Financial Leverage (Net Debt / EBITDA) 1,47x 1,29x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend